PRME
Prime Medicine·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
PRME Profile
Prime Medicine, Inc.
A biotechnology company that focused on cure genetic disorders by deploying Prime Editing technology
60 First Street, Cambridge, MA 02141
--
Prime Medicine, Inc., was incorporated in Delaware in September 2019. The company is a biotechnology company dedicated to delivering a new class of differentiated one-time therapeutic gene therapies — Prime Editors, which address the broadest spectrum of diseases by deploying Prime Editing technology.
